TickerFactsScreenerDevelopers

Summit Therapeutics Inc. (SMMT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $63.84M2020: $66.42M2021: $71.79M2022: $348.61M2023: $71.42M2024: $104.86M2025: $225.27M$225.27M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$225.27M+114.8%
2024$104.86M+46.8%
2023$71.42M-79.5%
2022$348.61M+385.6%
2021$71.79M+8.1%
2020$66.42M+4.0%
2019$63.84M—